Standard v1.1 · by product

Who sells retatrutide

13 sellers in the ledger list retatrutide on their own pages. Retatrutide is an investigational GIP, GLP-1 and glucagon receptor agonist from Eli Lilly in phase 3 trials, with no FDA-approved product.

Each record below shows how the seller did on the same eight criteria: a named prescriber, prescription gating, the filling pharmacy, compounding disclosure, testing documents, a business address, a printed price and FDA enforcement. Sellers are listed alphabetically; nothing here is a ranking.

Research vendors 13

Other products in the ledger

SemaglutideTirzepatideLiraglutideSermorelinNAD+GlutathionePT-141GHK-CuTesamorelinBPC-157TB-500MOTS-cSemaxEpitalonIpamorelinCagrilintide

A seller appears here when its own pages listed retatrutide on the date its record was taken. What each criterion requires: the Standard. How checks are performed: method.